ABSTRACT
Calorie restriction (CR) slows aging and increases healthy lifespan in model organisms. We tested if CR slowed biological aging in humans using DNA methylation analysis of blood samples from N=197 participants in the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE™) randomized controlled trial. We quantified CR effects on biological aging by comparing change scores for six epigenetic-clock and Pace-of-Aging measures between n=128 CR-group and n=69 ad-libitum-control-group participants at 12- and 24-month follow-ups. CR effects were strongest for DunedinPACE Pace of Aging (12-month Cohen’s d=0.3; 24-month Cohen’s d=0.2, p<0.01 for both), followed by DunedinPoAm and the GrimAge epigenetic clock, although effects for these measures were not statistically different from zero (p>0.08). CR effects for other epigenetic clocks were in the opposite direction (all p>0.15). CALERIE intervention slowed Pace of Aging but showed minimal effect on epigenetic clocks hypothesized to reflect longer term accumulation of aging burden.
Competing Interest Statement
DLC and DWB are listed as inventors on a Duke University and University of Otago invention that was licensed to a commercial entity.
Clinical Trial
This article reports data generated from stored biospecimens collected as part of the CALERIE Trial, registered as NCT00427193
Funding Statement
This research was supported by R01AG061378. Additional support for VBK was provided by R01AG054840. We thank the CALERIE Research Network R33AG070455 for their assistance in this project and The Dunedin Study R01AG032282 for facilitating early access to the DunedinPACE DNA methylation algorithm.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research reported in this article was overseen by the Institutional Review Board of the Columbia University Irving Medical Center (AAAS2948)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All non-genomic data are available from the CALERIE biorepository (calerie.duke.edu). Genomic data are available from corresponding author until March 2024, at which point they will be available from the CALERIE biorepository.
